Cargando…

Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins

Amphotericin B is a low soluble broad-spectrum antifungal agent. Cyclodextrins can be added to amphotericin formulations to enhance both their solubility and antifungal properties. Semisolid amphotericin formulations containing gamma cyclodextrin (AGCD) were prepared and compared with two reference...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Castillo, Carmen, Rodríguez-Fernández, Carmina, Córdoba, Manuel, Torrado, Juan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321561/ https://www.ncbi.nlm.nih.gov/pubmed/30567325 http://dx.doi.org/10.3390/molecules23123349

Ejemplares similares

Design of amphotericin B oral formulation for antifungal therapy
por: Liu, Min, et al.
Publicado: (2017)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Do Ophthalmic Solutions of Amphotericin B Solubilised in 2-Hydroxypropyl-γ-Cyclodextrins Possess an Extended Physicochemical Stability?
por: Chennell, Philip, et al.
Publicado: (2020)

Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis
por: de Bastiani, Fernanda Walt Mendes da Silva, et al.
Publicado: (2020)

Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B()
por: Cho, Do-Yeon, et al.
Publicado: (2017)

Fingolimod Potentiates the Antifungal Activity of Amphotericin B
por: Wei, Lu-Qi, et al.
Publicado: (2021)

Polypseudorotaxanes of Pluronic® F127 with Combinations of α- and β-Cyclodextrins for Topical Formulation of Acyclovir
por: Di Donato, Cristina, et al.
Publicado: (2020)

Effect of Primary Packaging Material on the Stability Characteristics of Diazepam and Midazolam Parenteral Formulations
por: Rodríguez Fernández, María José, et al.
Publicado: (2022)

Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
por: Ceballos, Laura, et al.
Publicado: (2012)

Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
por: Faustino, Célia, et al.
Publicado: (2020)

Atorvastatin-loaded emulsomes foam as a topical antifungal formulation
por: Eita, Alaa S., et al.
Publicado: (2022)

NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency
por: Burgess, Braydon L, et al.
Publicado: (2013)

In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration
por: Rodríguez-Torrado, Marta, et al.
Publicado: (2022)

Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B
por: Banerjee, Dithi, et al.
Publicado: (2014)

Bio-Distribution and Pharmacokinetics of Topically Administered γ-Cyclodextrin Based Eye Drops in Rabbits
por: Kallab, Martin, et al.
Publicado: (2021)

Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)

Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations
por: Frézard, Frédéric, et al.
Publicado: (2022)

The Effect of Amphotericin B on the Water and Nonelectrolyte Permeability of Thin Lipid Membranes
por: Andreoli, Thomas E., et al.
Publicado: (1969)

Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres
por: Gharib, A, et al.
Publicado: (2011)

Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis
por: Saldanha, Camila Arruda, et al.
Publicado: (2016)

Branched amphotericin functional poly(N-isopropyl acrylamide): an antifungal polymer
por: Swift, Thomas, et al.
Publicado: (2021)

Nasal Gel Loaded with Amphotericin Nanotransferosomes as Antifungal Treatment for Fungal Sinusitis
por: Hosny, Khaled M., et al.
Publicado: (2020)

Lipase-Responsive Amphotericin B Loaded PCL Nanoparticles for Antifungal Therapies
por: Uroro, Evelyn Osehontue, et al.
Publicado: (2022)

Cyclodextrin’s Effect on Permeability and Partition of Nortriptyline Hydrochloride
por: Volkova, Tatyana, et al.
Publicado: (2023)

Physicochemical and Stability Evaluation of Topical Niosomal Encapsulating Fosinopril/γ-Cyclodextrin Complex for Ocular Delivery
por: Hnin, Hay Marn, et al.
Publicado: (2022)

Nephrotoxicity of three formulations of amphotericin B: trial sequential analysis
por: Caputo, Rosaria, et al.
Publicado: (2020)

An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety
por: Antillón, Armando, et al.
Publicado: (2016)

Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations
por: Beig, Avital, et al.
Publicado: (2013)

Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four Candida auris Clades: In Vitro and In Vivo Assays
por: Marena, Gabriel Davi, et al.
Publicado: (2023)

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
por: Akers, Kevin S, et al.
Publicado: (2015)

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
por: Adler-Moore, Jill, et al.
Publicado: (2019)

Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review
por: Bezerra, Lucas Soares, et al.
Publicado: (2020)

Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats
por: Radwan, Mahasen A., et al.
Publicado: (2017)

Cyclodextrin–polysaccharide-based, in situ-gelled system for ocular antifungal delivery
por: Fernández-Ferreiro, Anxo, et al.
Publicado: (2014)

Preparation of Topical Itraconazole with Enhanced Skin/Nail Permeability and In Vivo Antifungal Efficacy against Superficial Mycosis
por: Subedi, Laxman, et al.
Publicado: (2021)

Correction: Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations
por: Beig, Avital, et al.
Publicado: (2013)

Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials
por: Akbar, Noor, et al.
Publicado: (2022)

Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections
por: Wasan, Ellen, et al.
Publicado: (2022)

Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox
por: Peruzzu, Daniela, et al.
Publicado: (2023)

The Ion Permeability Induced in Thin Lipid Membranes by the Polyene Antibiotics Nystatin and Amphotericin B
por: Cass, Albert, et al.
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_pm2ojq1a9oq67ofab16csuom1c